2.4. Study endpoints
Sore
SECONDARY
The primary endpoint of the study was the percentage of responders defined as patients reporting at least a “slight relief” (Sore Throat Relief Rating Scale [STRRS] score ≥ 1) at T2min after the first application of benzydamine HCl (spray or lozenges).As secondary endpoints, the comparison between the 2 treatment groups was assessed to determine: the percentage of patients recording a first perceived ST relief (STRRS score ≥1) assessed at T1min; the percentage of patients recording a meaningful ST relief (STRRS score ≥ 3) assessed from T5min to T120minutes after a single dose administration (Table 